Identifying fusion genes from paired-end ribonucleic acid (rna) sequencing (rna-seq) data has the advantage that...
Developer and provider of genomic and healthcare data solutions MediSapiens has announced it will extend its solution delivery network by offering its Explorer™ Platform based solutions in Microsoft’s Azure Cloud.
The first-stage target customers on Azure include Finnish healthcare facilities and institutions, while the partnership reinforces the global reach for MediSapiens solutions.
The Explorer™ Platform comprises scalable tools for both small and large clinical, genomic, and biomedical data curation, management, and analytics. The tools are built to ensure that the rapidly growing data amounts generated by healthcare facilities and their partners are curated to a harmonised, integrated, and quality-assured format. This data can then be reliably and efficiently used for data-driven research for personalised medicine development and other scientific and healthcare purposes.
Chief commercial officer at MediSapiens Marko Kuisma says: "Microsoft is a prominent cloud platform provider for healthcare. Microsoft’s focus on data security and regulatory compliance are perfectly matched with MediSapiens’ endeavors on bringing world class genomic, clinical and biomedical big data solutions to benefit healthcare facilities and clinical research not only in Finland but globally.
"We’re very excited about the partnership. Our collaboration with Microsoft means that many healthcare facilities will be able to implement MediSapiens’ data solutions to their existing IT infrastructure. Customers will be able to run heavy-duty genomic and clinical data analytics, but the data will never need to exit the customer’s firewalls."
Microsoft’s Azure Cloud solutions are used by healthcare facilities worldwide. Microsoft follows its strategy to partner with companies on the healthcare application layer, while providing secure cloud infrastructures for its customers.
Partner business and development lead of Microsoft Finland Matti Antila said: "We are very pleased to have innovative partners like MediSapiens to provide world class services using our technology.
"Having genomic data interpretation solutions on Microsoft Azure jointly with MediSapiens is a step forward in using the best technology available for improved healthcare services. We are living in an exciting era where we can learn so much from increasing amounts of genomic, clinical, and biomedical data through efficient data interpretation and analytics solutions.
"Partnering with MediSapiens opens up opportunities for new methods and practices for personalised medicine, paving the way for better treatments. Thanks to Microsoft Azure’s ubiquitous nature, together we can serve customers locally and globally in a safe and fast-paced mobile first, cloud first world."
MediSapiens continues to offer its solutions on several delivery platforms, with client hosted, MediSapiens server cluster hosted, and private and commercial cloud hosted options.
Innatoss Laboratories and MediSapiens have partnered to develop a novel Lyme borreliosis (LB) diagnostic interpretation...
MediSapiens has collaborated with The Pistoia Alliance, a global, non-profit alliance of life science companies,...
MediSapiens has announced it will be attending the International Society and the International Foundation for...